Contact

Careers
Country websites

Investors

FME_Communication_Financial_Results_EN_2025_Q3_4_3

Conference Call on Q3 2025 financial results

The Conference Call on Q3 took place on November 4, 2025 

Learn more
Investor Presentation

Investor Presentation

Our current presentation for investors including strategy, financial data and outlook

Learn more
Capital_Markets_Day

Capital Markets Day 2025

Our Capital Markets Day took place in London on June 17, 2025

Learn more
204040-GlenBurnie, Glen Burnie, Maryland - November 22: Fresenius Kidney Care on November 22, 2024 (Photo by Ferran Traite Soler/Getty Images for Fresenius Medical Care

Sustainability

Managing sustainability successfully means creating lasting value – economically, ecologically and socially.

Learn more
Contacts

Contacts

The Investor Relations Team is pleased to answer your questions regarding our share, financial performance or other capital market related questions.

Learn more
Meeting_room

Q3 2025 financial results

Investor Presentation

Investor Presentation

Investment

Capital Markets Day 2025

Sustainability

Sustainability

Contact

Contact

Helen Giza
In Q3 2025, we continued the momentum and further accelerated revenue growth. Conversion into operating income growth increased as planned for the third consecutive quarter, underlining our continued operational and financial progress.
Our Group operating income margin of 11.7% extended well into the implied full year 2025 range of 11% to 12%. This demonstrates important progress on our trajectory to deliver our full year 2025 financial outlook.
We advanced our FME Reignite strategy for value creation with the launch of the first tranche of our initial share buyback program, the ownership increase in our Value-Based Care entity Interwell Health and the continued rollout of the 5008X in the U.S. For 2025, we are well on track to achieve our commitments, while we are excited about what lies ahead with FME Reignite.

Helen Giza

Chief Executive Officer

Latest Documents

Financial Calendar

List View

Grid View

01/27/2026 - 02/23/2026 | Reporting

Q4/FY 2025 Quiet Period

Save the date

02/24/2026 | Reporting

Report on 4th quarter 2025: Earnings Release and Conference Call

Save the date

02/27/2026 | Reporting

Q4 financial report

Save the date

04/21/2026 - 05/04/2026 | Reporting

Q1 2026 Quiet Period

Save the date

Event Calendar

List View

Grid View

01/08/2026 | Conference

Oddo BHF Forum

Lyon

Save the date

01/12/2026 | Conference

Commerzbank/Oddo BHF German Investment Seminar

New York

Save the date

01/12/2026 - 01/13/2026 | Conference

J.P. Morgan 2026 Healthcare Conference

San Francisco

Save the date

01/19/2026 | Conference

German Corporate Conference

Frankfurt

Save the date

You are interested in our news?

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our 
privacy policy.

Media center
See all stories
No Results Found
See all stories
PREVIOUS
    NEXT
    Events
    See all events
    No Results Found
    See all events
    PREVIOUS
      NEXT
      Contact
      Country websites

      All contact information

      Social Media

      © Fresenius Medical Care AG 2025

      Privacy policy

      Cookie settings

      Imprint